vs

Side-by-side financial comparison of ADC Therapeutics SA (ADCT) and CSP INC (CSPI). Click either name above to swap in a different company.

ADC Therapeutics SA is the larger business by last-quarter revenue ($23.1M vs $12.0M, roughly 1.9× CSP INC). On growth, ADC Therapeutics SA posted the faster year-over-year revenue change (36.4% vs -23.2%). Over the past eight quarters, ADC Therapeutics SA's revenue compounded faster (13.7% CAGR vs -6.3%).

ADC Telecommunications, Inc. was a communications company in Eden Prairie, Minnesota, a southwest suburb of Minneapolis. It was acquired by TE Connectivity in December 2010 and ceased to exist as a separate entity. ADC products were sold by CommScope after it acquired the Broadband Network Solutions business unit from TE Connectivity in August 2015.

CSP Inc. is a U.S.-based technology firm offering cybersecurity solutions, managed IT services, high-performance computing systems, and IT consulting support. It serves enterprises across healthcare, finance, manufacturing, and public sectors in North America and select global markets.

ADCT vs CSPI — Head-to-Head

Bigger by revenue
ADCT
ADCT
1.9× larger
ADCT
$23.1M
$12.0M
CSPI
Growing faster (revenue YoY)
ADCT
ADCT
+59.5% gap
ADCT
36.4%
-23.2%
CSPI
Faster 2-yr revenue CAGR
ADCT
ADCT
Annualised
ADCT
13.7%
-6.3%
CSPI

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
ADCT
ADCT
CSPI
CSPI
Revenue
$23.1M
$12.0M
Net Profit
$91.0K
Gross Margin
39.3%
Operating Margin
-77.7%
-0.9%
Net Margin
0.8%
Revenue YoY
36.4%
-23.2%
Net Profit YoY
-80.7%
EPS (diluted)
$0.04
$0.01

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ADCT
ADCT
CSPI
CSPI
Q4 25
$23.1M
$12.0M
Q3 25
$15.8M
$14.5M
Q2 25
$18.1M
$15.4M
Q1 25
$17.4M
$13.1M
Q4 24
$16.9M
$15.7M
Q3 24
$18.0M
$13.0M
Q2 24
$17.0M
$13.1M
Q1 24
$17.8M
$13.7M
Net Profit
ADCT
ADCT
CSPI
CSPI
Q4 25
$91.0K
Q3 25
$-41.0M
$-191.0K
Q2 25
$-56.6M
$-264.0K
Q1 25
$-38.6M
$-108.0K
Q4 24
$472.0K
Q3 24
$-44.0M
$-1.7M
Q2 24
$-36.5M
$-185.0K
Q1 24
$-46.6M
$1.6M
Gross Margin
ADCT
ADCT
CSPI
CSPI
Q4 25
39.3%
Q3 25
36.6%
Q2 25
28.8%
Q1 25
32.0%
Q4 24
29.1%
Q3 24
28.4%
Q2 24
35.0%
Q1 24
47.3%
Operating Margin
ADCT
ADCT
CSPI
CSPI
Q4 25
-77.7%
-0.9%
Q3 25
-196.6%
-3.7%
Q2 25
-244.1%
-7.9%
Q1 25
-163.5%
-7.6%
Q4 24
-191.8%
-2.3%
Q3 24
-197.4%
-15.7%
Q2 24
-170.5%
-5.5%
Q1 24
-188.3%
9.0%
Net Margin
ADCT
ADCT
CSPI
CSPI
Q4 25
0.8%
Q3 25
-260.1%
-1.3%
Q2 25
-313.2%
-1.7%
Q1 25
-221.8%
-0.8%
Q4 24
3.0%
Q3 24
-244.1%
-12.7%
Q2 24
-214.6%
-1.4%
Q1 24
-261.1%
11.6%
EPS (diluted)
ADCT
ADCT
CSPI
CSPI
Q4 25
$0.04
$0.01
Q3 25
$-0.30
$-0.02
Q2 25
$-0.50
$-0.03
Q1 25
$-0.36
$-0.01
Q4 24
$-0.26
$0.05
Q3 24
$-0.42
$-0.17
Q2 24
$-0.38
$-0.02
Q1 24
$-0.56
$0.16

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ADCT
ADCT
CSPI
CSPI
Cash + ST InvestmentsLiquidity on hand
$261.3M
$24.9M
Total DebtLower is stronger
Stockholders' EquityBook value
$-185.8M
$44.8M
Total Assets
$323.1M
$69.2M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ADCT
ADCT
CSPI
CSPI
Q4 25
$261.3M
$24.9M
Q3 25
$234.7M
$27.4M
Q2 25
$264.6M
$26.3M
Q1 25
$194.7M
$29.5M
Q4 24
$250.9M
$30.7M
Q3 24
$274.3M
$30.6M
Q2 24
$300.1M
$28.9M
Q1 24
$234.3M
$27.1M
Stockholders' Equity
ADCT
ADCT
CSPI
CSPI
Q4 25
$-185.8M
$44.8M
Q3 25
$-238.2M
$44.6M
Q2 25
$-199.2M
$47.5M
Q1 25
$-238.2M
$47.5M
Q4 24
$-202.6M
$47.5M
Q3 24
$-171.9M
$47.3M
Q2 24
$-131.7M
$48.1M
Q1 24
$-194.4M
$48.2M
Total Assets
ADCT
ADCT
CSPI
CSPI
Q4 25
$323.1M
$69.2M
Q3 25
$289.8M
$71.2M
Q2 25
$321.6M
$66.8M
Q1 25
$272.5M
$67.1M
Q4 24
$322.0M
$67.5M
Q3 24
$349.1M
$69.4M
Q2 24
$371.8M
$66.8M
Q1 24
$308.0M
$64.2M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ADCT
ADCT
CSPI
CSPI
Operating Cash FlowLast quarter
$-31.1M
$-2.9M
Free Cash FlowOCF − Capex
$-3.0M
FCF MarginFCF / Revenue
-25.1%
Capex IntensityCapex / Revenue
0.0%
0.9%
Cash ConversionOCF / Net Profit
-32.04×
TTM Free Cash FlowTrailing 4 quarters
$-2.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ADCT
ADCT
CSPI
CSPI
Q4 25
$-31.1M
$-2.9M
Q3 25
$-29.6M
$1.9M
Q2 25
$-24.1M
$-3.3M
Q1 25
$-56.3M
$1.9M
Q4 24
$-21.9M
$1.7M
Q3 24
$-25.0M
$-1.5M
Q2 24
$-32.8M
$2.4M
Q1 24
$-44.1M
$1.7M
Free Cash Flow
ADCT
ADCT
CSPI
CSPI
Q4 25
$-3.0M
Q3 25
$1.7M
Q2 25
$-3.3M
Q1 25
$-56.6M
$1.9M
Q4 24
$-21.9M
$1.7M
Q3 24
$-25.3M
$-1.5M
Q2 24
$-32.9M
$2.4M
Q1 24
$-44.6M
$1.6M
FCF Margin
ADCT
ADCT
CSPI
CSPI
Q4 25
-25.1%
Q3 25
11.5%
Q2 25
-21.7%
Q1 25
-325.2%
14.5%
Q4 24
-129.8%
10.8%
Q3 24
-140.2%
-11.7%
Q2 24
-193.0%
17.9%
Q1 24
-250.0%
11.9%
Capex Intensity
ADCT
ADCT
CSPI
CSPI
Q4 25
0.0%
0.9%
Q3 25
0.0%
1.6%
Q2 25
0.0%
0.4%
Q1 25
1.5%
0.1%
Q4 24
0.5%
0.3%
Q3 24
1.2%
0.1%
Q2 24
0.2%
0.3%
Q1 24
3.0%
0.1%
Cash Conversion
ADCT
ADCT
CSPI
CSPI
Q4 25
-32.04×
Q3 25
Q2 25
Q1 25
Q4 24
3.69×
Q3 24
Q2 24
Q1 24
1.04×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ADCT
ADCT

Segment breakdown not available.

CSPI
CSPI

Products$6.7M56%
Services$5.3M44%

Related Comparisons